BMYB34:BVMF
Bristol-Myers Squibb Company BDR
R$296.57
0.00%
(0.00) 1D
Oct 19, 12:56:54 PM GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BMYB34...
Mkt. cap
125.55B
Avg. vol.
10.00
Volume
0.00
52-wk high
R$347.15
52-wk low
R$221.72
Shares outstanding
2.04B
No. of employees
32K
Mkt. cap
125.55B
Avg. vol.
10.00
Volume
0.00
52-wk high
R$347.15
52-wk low
R$221.72
Shares outstanding
2.04B
No. of employees
32K
News stories
From web sources and news partners
24/7 Wall St.
·
1 hour ago
Moderna Jumps 7% While Melanoma Vaccine Data Looms; Bristol Myers Squibb Rises 5%, Pfizer Advances 2%
TradingKey
·
5 hours ago
Bristol-Myers Squibb Co Stock (BMY) Moved Up by 3.39% on Oct 20: Key Drivers Unveiled
MarketBeat
·
8 hours ago
Bristol Myers Squibb Company (NYSE:BMY) Stock Has Average Target Price of $64.88 According to Analysts
Trefis
·
11 hours ago
What Is Going On With Bristol Myers Squibb Stock?
Profile
Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban for people with atrial fibrillation; nivolumab, used to treat certain types of cancer; lenalidomide, used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes; abatacept, used to treat autoimmune diseases such as rheumatoid arthritis; pomalidomide, an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma; ipilimumab, to treat cancer; and luspatercept for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. In 2025, 69% of the company's revenues came from the United States.
The company is ranked 94th on the Fortune 500 and 173rd on the Forbes Global 2000. Wikipedia
About Bristol-Myers Squibb Company BDR
CEOChris Boerner
Employees32.5K
Founded1887
HeadquartersNew York, New York, United States
SectorPharmaceutical industry
Websitebms.com